Search - tctmd.com

Displaying 81 - 98 of 98

Sort: Relevancy | Date

News Conference News EuroPCR 2016

Closer Look at Effects of CAD on TAVR Outcomes Unearths Grim Prognosis

Yael L. Maxwell

May 19, 2016

Presentation EuroPCR 2016

Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease with Severe Mitral Annular Calcification

Presenter: Mayra Guerrero

May 18, 2016

News Conference News EuroPCR 2016

‘Obesity Paradox’ Alive, Well, and Mysterious After TAVR

Yael L. Maxwell

May 18, 2016

News Conference News EuroPCR 2016

WIN-TAVI Registry Homes in on TAVR Outcomes Unique to Female Patients

Caitlin E. Cox

May 17, 2016

News Conference News EuroPCR 2016

‘Signal’ of Poor Durability Seen With First-Generation TAVR Devices

Caitlin E. Cox

May 17, 2016

News Conference News EuroPCR 2016

EuroPCR 2016: Mitral Innovations, LAA Closure, and ‘TAVI, TAVI, TAVI’

Shelley Wood

May 16, 2016

News Conference News EuroPCR 2015

New, Old CoreValve Iterations Showing Reductions in Pacemaker Need, Paravalvular Leak

Yael L. Maxwell

May 22, 2015

News Conference News EuroPCR 2015

Sapien 3 Experience in Europe, Canada Shows Low Mortality, Paravalvular Leak at 30 Days

Yael L. Maxwell

May 21, 2015

News Conference News EuroPCR 2015

DEFLECT III: 30-Day Results Show Successful, Safe TAVR With Novel Neuroprotection Device

Yael L. Maxwell

May 20, 2015

Presentation EuroPCR 2015

The NOTION Trial

Presenter: Lars Sondergaard

May 19, 2015

News Conference News EuroPCR 2015

NOTION: 2-Year Data Show Positive Outlook for TAVR in Lower-Risk Patients

Yael L. Maxwell

May 19, 2015

News Conference News EuroPCR 2014

New Iteration of Sapien Device Associated with Low Rates of Early Mortality, Stroke

L.A. McKeown

May 23, 2014

News Conference News EuroPCR 2014

UK Registry Finds Long-Term Survival After TAVR Depends on Patient Characteristics

Caitlin E. Cox

May 22, 2014

Presentation EuroPCR 2013

Repositionable Percutaneous Replacement of a Stenotic Aortic Valve through Implantation of the Lotus Valve System

Presenter: 203171|Ian Meredith

May 31, 2013

Presentation EuroPCR 2013

First Report of One-Year Outcomes of the REPRISE I Feasibility Study of the Repositionable Lotus Aortic Valve Replacement System

Presenter: 203171|Ian Meredith

May 31, 2013

News Conference News EuroPCR 2013

Deflection Device Reduces Volume, Not Number, of Cerebral Lesions During TAVR

Jason Kahn

May 24, 2013

Presentation EuroPCR 2013

Prospective, Multicenter Evaluation of the 18FDirectFlow TranscatheterAortic Valve: The DISCOVER Trial: Final Study Enrollment

Presenter: Joachim Schofer

May 22, 2013

Presentation EuroPCR 2013

First Report of the DEFLECT I Trial

Presenter: Michael Mullen

May 22, 2013

Advertisement

Closer Look at Effects of CAD on TAVR Outcomes Unearths Grim Prognosis

Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease with Severe Mitral Annular Calcification

‘Obesity Paradox’ Alive, Well, and Mysterious After TAVR

WIN-TAVI Registry Homes in on TAVR Outcomes Unique to Female Patients

‘Signal’ of Poor Durability Seen With First-Generation TAVR Devices

EuroPCR 2016: Mitral Innovations, LAA Closure, and ‘TAVI, TAVI, TAVI’

New, Old CoreValve Iterations Showing Reductions in Pacemaker Need, Paravalvular Leak

Sapien 3 Experience in Europe, Canada Shows Low Mortality, Paravalvular Leak at 30 Days

DEFLECT III: 30-Day Results Show Successful, Safe TAVR With Novel Neuroprotection Device

The NOTION Trial

NOTION: 2-Year Data Show Positive Outlook for TAVR in Lower-Risk Patients

New Iteration of Sapien Device Associated with Low Rates of Early Mortality, Stroke

UK Registry Finds Long-Term Survival After TAVR Depends on Patient Characteristics

Repositionable Percutaneous Replacement of a Stenotic Aortic Valve through Implantation of the Lotus Valve System

First Report of One-Year Outcomes of the REPRISE I Feasibility Study of the Repositionable Lotus Aortic Valve Replacement System

Deflection Device Reduces Volume, Not Number, of Cerebral Lesions During TAVR

Prospective, Multicenter Evaluation of the 18FDirectFlow TranscatheterAortic Valve: The DISCOVER Trial: Final Study Enrollment

First Report of the DEFLECT I Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content